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Abstract 
Pericytes, the mural cells of blood capillaries, have an important role in the regulation 
of the blood flow through the capillaries. In many pathological conditions in the 
vascular network, pericytes are the main cause of a disease. They contain contractile 
proteins that are attached to fibronectin patches in a shared basement membrane with 
the capillary. Therefore, the pericyte is able to exert forces and regulate the vessel 
diameter. In our work, the main question was how the forces of pericytes relate in 
hypoxia and ischemia. We showed that pericytes in simulated hypoxia have a decrease 
in force application and an increase in cell spreading area compared to normal 
conditions. In simulated ischemia pericytes decrease their cell spreading area and have 
a slightly decreased force application. A second question we discussed is how the 
substrate stiffness plays a role in the force application in normal conditions. The 
gradient of force application for a range of substrate stiffnesses of 11.6 to 137 kPa is 
dependent of the cell type. For fibroblasts the force and the cell spreading area 
increased with increasing substrate stiffness. However, pericytes show a high force 
application on low and high substrate stiffnesses and have a low force application on 
intermediate stiffnesses. In order to find the force that a cell exert, we used a model that 
mimiced the fibronectin patches in the basement membrane. Cells were seeded on 
micropillar arrays made of polydimethylsiloxane (PDMS) that were functionalized with 
fibronectin. The deflection of the pillars was used to calculate the force applied by the 
cell. 
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Introduction 
 
 
Pericytes, the mural cells of capillaries, emerged as important regulators of the vascular 
morphogenesis and function. As multi-functional members of the vascular unit, they 
control stability [1], and architecture of newly formed capillaries [2]. In addition, 
pericytes maintain the blood brain barrier [3], contribute to secretion and level regulation 
of basement forming proteins, and have stem cell properties [4]. Containing contractile 
proteins [5] they play a critical role in the regulation of the capillary diameter and blood 
flow [2]. Recent interest in pericytes stems from their involvement in diseases. In cerebral 
ischemia, the contractility and death of pericytes is involved. This leads to obstruction of 
capillaries and neuronal damage [6]. Yet there is no medication which prevents 
constriction and death of pericytes, because there is still a lot unknown. In this study we 
focus on the contractility of pericytes in hypoxic and ischemic conditions in vitro. Our 
motivation for such an in vitro approach is to set up a model in which environmental 
circumstances and drug application can be regulated very precisely and can be analysed 
unobscured by other factors. 
 
 
1.1 Pericytes regulate the capillary diameter 
Not only in diseases, such as cerebral ischemia, the contractility of pericytes is involved. 
In normal conditions the stiffness of vessels also influences the contractility. So are 
arteries and veins stiffer by their blood pressure than capillaries. Figure 1.1A shows the 
mural cell morphology in different branches of the vascular network. There is a smooth 
transition from smooth muscle cells (SMCs) around arterioles to pericytes around 
capillaries and back to SMCs around venules. SMCs wrap around arterioles and have a 
stellate shape around venules. Pericytes around capillaries have a round cell body and are 
extensively branched. They have many primary and secondary processes that run around 
the capillary. The secondary processes play a role in the attachment to the endothelial 
cells (ECs), the cell type that the capillary is made of. Figure 1.1B shows a schematic 
illustration of the binding between pericyte and EC. Normally the pericyte is separated 
from the capillary by a shared basement membrane. A direct contact between pericytes 
and the ECs happens through membrane invasions from either cell type, called peg-
socket contacts [7]. These contacts contain gap and adherence junctions [8]. Gap 
junctions allow transfer of molecules between pericytes and transfer of molecules 
between pericytes and ECs [9]. Adherence junctions maintain a cell-cell attachment with 
the help of N-cadherin adhesion proteins [10]. However, the main mechanical binding of  
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pericytes to ECs happens through fibronectin adhesion plaques embedded into the 
laminin rich basement membrane. Integrins mediate the adhesion between fibronectin 
and the actin cytoskeleton of pericytes [11]. This leads us to the pericyte function in 
which we are interested: the regulation of the capillary diameter and thus blood flow, by 
pericyte contraction. Through the binding via the actin cytoskeleton pericytes can apply 
force on the fibronectin, which is located on the capillary. This force application, we want 
to measure in our study.  
 
   
Figure 1.1 [7]: A) The morphology of mural cells in different branches of the vascular network. 
B) The anatomy of a pericyte embedded in the vascular basement membrane. The pericyte (P) 
has several attachments with the endothelial cell (E), such as peg-socket holes and fibronectin 
adhesion plaques. 
 
There are two main questions that we are focussing on in this thesis. The first question 
relates to the behavior of pericytes in the hypoxic and ischemic conditions. The second 
question is about the influence of the substrate stiffness in normal conditions. The 
research questions that will be discussed and answered in this thesis are: 
 
 What is the influence of hypoxia and ischemia on the force application and the 
cell spreading area of pericytes? 
 What is the influence of different substrate elasticities on the force application 
and the cell spreading area of pericytes and fibroblasts in normal conditions? 
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1.2 Pericytes in hypoxia and ischemia 
To give an answer to our research questions, a hypothesis is created beforehand. In order 
to compose a hypothesis about the first research question, theory about pericytes in 
hypoxic and ischemic conditions is explained. First, the main signaling in hypoxia is 
explained. Secondly, the behavior of pericytes is described by a previous study done by 
Hall et al. 
 
 
1.2.1 Hypoxia 
Hypoxia, the condition where oxygen is lacking, can be obtained by two methods. The 
first method is by depriving the oxygen from the sample. The other method is by 
chemically stabilizing hypoxia inducible factors (HIFs). In hypoxia, HIFs are the main 
regulators of the homeostasis. HIFs consist of three alpha subunits and a beta part, also 
known as Arnt [12]. Only if both are present, induction of angiogenetic factors is resulted. 
 
In normal oxygen conditions (normoxia), HIF-alpha is degradated. Prolyl hydroxylase 
enzymes (PHD) hydroxylate HIF-alpha under influence of oxygen. The hydroxylated 
HIF-alpha binds to the von Hippel-Lindau complex (VHL), which causes the 
degradation. In hypoxia, oxygen becomes limiting and as a result hydroxylation of HIF-
alpha, binding to the VHL and degradation cannot take place [12]. HIF-alpha 
concentration increases [13] and HIF-alpha binds to the HIF-beta subunit. The complex 
relocates to the nucleus, where it binds to hypoxia response elements (HRE) in the DNA 
[14]. This in turn promotes survival by induction of angiogenetic factors, see figure 1.2. 
For pericytes the main angiogenic molecules are vascular endohelial growth factor 
(VEGF), angiopoietin-2, fibroblast growth factor (FGF) and platelet-derived growth 
factor beta (PDGF-B). VEGF and angiopoietin-2 function in the initiation of the 
angiogenesis, by playing a role in the detachment of pericytes and degradation of the 
basement membrane. VEGF also has a function, together with FGF and PDGF-B, in the 
neovessel formation by pericyte proliferation and migration. Finally, PDGF-B functions 
in the maturation by the attachment of pericytes [12]. Of course there are a lot more 
angiogenic molecules that regulate the angiogenesis. A second result of low oxygen 
conditions is a switch to glycolytic metabolism instead of oxidative [15] for the 
production of ATP.  
 
We hypothesize that pericytes have a reduced force application. The ATP production via 
the glycolytic metabolism is less efficient and therefore less energy is available. In the 
initiation of the angiogenesis, pericytes detach under influence of VEGF and 
angiopoietin-2. This suggests also a force decreasement of pericytes. 
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Figure 1.2 [12]: Regulation of the HIF activity in normoxia, where HIF-alpha is degraded and 
in hypoxia, where HIF-alpha concentration increases. HIF-alpha accumulation provides binding 
to HIF-beta. This leads to migration to the cell nucleus, where binding to hypoxia response 
elements (HRE) results in increase of angiogenetic factors. 
 
 
1.2.2 Ischemia 
Ischemia is the lack of oxygen in combination with a lack of glucose. Hence an energy 
source for cells is missing. Previous study by Hall et al. explained that because of lacking 
ATP, Ca²+ levels rise in pericytes which makes them contract [6], see figure 1.3. They 
showed that 40% of pericytes on capillaries in cerebral cortical slices die after one hour 
of oxygen and glucose deprivation. If in addition ATP glycolyse and oxidative 
phosphorylation is inhibited, an increase to 100% of pericytes die after one hour. Due to 
the lack of ATP molecules myosin and actin cannot separate from one another, which 
leads to death in rigor [16]. These dead stiff pericytes prevent reflow of blood through 
capillaries, resulting in neuronal damage [6]. 
 
Assuming this information, we hypothesize that pericytes in ischemia have an increased 
force application compared to normal conditions. This is interpreted due to the rise of 
Ca²+ levels. Another hypothesis is that the cell spreading area becomes very small due to 
contraction and death.  
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Figure 1.3 [6]: Signalling to pericytes in ischemia, where ATP is missing because of the lacking 
glucose. This results in an increase of calcium levels in pericytes, which makes them contract. 
Death in rigor of pericytes by the lacking ATP results in long lasting blocked capillaries and 
neuronal damage. 
 
 
1.3 Model 
For our experiments to be performed, we make use the following model. Micropillar 
arrays made of poly(demethyl-)siloxane (PDMS) are used as a substrate for cells. The 
pillartops are functionalized with fibronectin to mimic the fibronectin deposits in the 
basement membrane between pericytes and ECs. By varying the height of the pillars, we 
are able to regulate the effective elasticities of the micropillar arrays. Besides micropillars 
enable us to measure the forces pericytes apply in vitro. The deflections of the 
micropillars caused by the pulling of cells can be monitored and therefore cellular 
traction forces can be measured. Such an in vitro approach allows us to study pericyte 
behavior in hypoxic and ischemic conditions by tuning oxygen and glucose levels.  
 
Because in vivo, pericytes are hard to distinguish from SMC and no clear markers for 
pericytes are found [7], we use induced pluripotent stem cell (iPSC)-derived pericytes in 
our experiments. This method obtaining pericytes is much more convenient than 
extracting them from the body, because 1) the adjustment of the derivation into pericytes 
is more precise and 2) this method obtains a large amount of pericytes in a short time (2-
3 weeks) [17]. 
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Methods 
 
2.1 Cell culture 
SV80, a human fibroblast cell line, were cultured in high glucose DMEM (Dulbecco’s 
Modified Eagle Medium, GIBCO, USA) supplemented with 10% fetal bovine serum 
(FBS), 25 ug/ml penicillin and 25 ug/ml streptomycin. CD31- cells, (iPSC)-derived 
human pericytes were obtained from C. L. Mummery group (LUMC). CD31- cells were 
cultured in high glucose DMEM supplemented with 10% FBS, 25 ug/ml penicillin and 
25 ug/ml streptomycin.  
 
 
2.2 PDMS micropillar array technology 
2.2.1 PDMS micropillar array preparation 
Silicon molds are used to make the PDMS micropillar arrays. The silicon molds have a 
hexagonal pattern of cylindrical holes in it. The diameter of these holes is 2 μm and have 
a spacing of 2 μm. The depth of the holes varies for different molds to obtain different 
substrate stiffnesses. Increasing the hight of the pillars, decreases the global stiffness.  
For our experiments micropillars with an effective substrate elasticity of 11.6, 29.5, 47.2 
and 137 kPa were used.  
 
The cylindrical holes in the silicon wafers are made using deep reactive ion etching 
(DRIE), which allows the holes to have a high aspect ratio and a highly vertical wall [18]. 
 
At the sides of the micropillar array 50 μm high spacers are arranged. The spacers are 
meant for inverted imaging with the intention of not crushing the cells when the 
micropillar array is inverted. Inverted imaging is used, because the working distance of 
the microscope is about 170 μm. Inverting the pillar array onto a 100 μm thick coverslip, 
the sample is within the working distance of the objective, see figure 2.1 [19]. 
 
 
 
 
 
 
 14 
 
 
 
 
Figure 2.1 [19] (not in scale): Making use of inverted imaging, the sample, seeded on 
micropillars next to spacers of 50 μm and imaged on a 100 μm thick coverslip, stays within the 
working distance of 170 μm.  
 
The silicon wafers were silanized by vapor deposition of trichloro(1H, 1H, 2H, 2H-
perfluoroctyl)silane (Sigma Aldrich) for one hour in 7 mbar or two hours in 10 mbar. The 
PDMS was mixed in a 10:1 weight ratio of the base mixed with its curing agent. The 
mixture was poured over the silicon wafers. Subsequally, PDMS polymerized for 20 
hours in 110 °C. After 20 hours of curing the PDMS was left for 60 minutes to cool down 
and the pillar array could be peeled off the mold, see figure 2.2A. 
 
 
2.2.2 PDMS micropillar array functionalization with proteins of interest 
To allow cell attachment to the PDMS, micropillar arrays were functionalized with 
fibronectin using micro contact printing, described in [20]. We made a flat PDMS stamp 
using a flat silicon wafer on which PDMS in a 1:30 cure:base ratio was cured. Shortly a 
fibronectin mixture of unlabeled fibronectin and Alexa 647 labeled fibronectin in ratio 
of 5:1 in water was applied onto the PDMS stamps. For efficient micro contact printing, 
the surface of the micropillars needs to have more favorable properties for the fibronectin 
to transfer than to remain on the stamp. The main property is the relative hydrophobicity 
of the substrate and stamp [20]. After we activated the PDMS micropillar arrays with 
ultraviolet/Ozone treatment to make the micropillar arrays more hydrophilic [21], the 
stamp could be applied to the PDMS micropillar arrays, see figure 2.2B,C. To prevent 
collapsing the pillars during the removal of the stamp, the pillars were submerged in 
100% ethanol. When removing the stamp in air, water will condensate between the 
pillars. Because of the high surface tension of water this results in pillars pulling together. 
Ethanol has a low surface tension and could therefore flow between the pillars. After 
removal of the stamp, the 100% ethanol was replaced by 70% ethanol in water and then 
by 0,1% pluronic in phosphate buffered saline (PBS). The pluronic makes sure that cell 
attachment to pillars that are not covered with fibronectin will not take place. All of this 
was done in a sterile environment. 
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Image 2.2 (not in scale): A) PDMS in a base:cure ratio of 10:1 was poured over silicon wafers. 
The wafers produce pillars of a certain height and therefore a certain stiffness. Next to the array 
of pillars 50μm spacers are located at both sides. After the PDMS was polymerized, the 
micropillar array was pulled out of the wafer. B) For the stamping, a droplet of unlabeled and 
labeled fibronectin in a ratio of 5:1 was applied on a flat PDMS stamp of a 30:1 base:cure ratio. 
After incubation the droplet was washed away with sterile water. C) The flat stamp is laid inverted 
on the pillar array and after 15 minutes incubation the stamp is removed in 100% ethanol to 
prevent collapsing of the pillars. The tops of the pillars are now functionalized with labeled 
fibronectin.  
 
 
2.3 In vitro modelling of hypoxia and ischemia 
2.3.1 Simulated hypoxia, chemical stabilization of HIF-alpha  
Hypoxia was simulated by the addition of dimethyloxaloylglycine (DMOG, Sigma-
Aldrich). DMOG inhibits hydroxylation of HIF-alpha by blocking PHD [15], which 
results in the same main signalling as in hypoxia (see chapter 1.2.1). The concentration 
range of DMOG, that was nontoxic for CD31- cells, was first determined. This was done 
looking at the viability of CD31- cells on DMOG incubation for 48 hours. CD31- cells 
were incubated in medium described above supplemented with increasing concentrations 
DMOG for 48 hours to get the effect of hypoxia. 
 
Secondly, CD31- cells were incubated in medium supplemented with the later 
determined concentration DMOG for 40 hours. Subsequally, CD31- cells were seeded 
on functionalized pillars, using all liquids provided with the determined concentration 
DMOG, to prevent degradation of HIF-alpha. Live imaging was done four and eight 
hours after seeding CD31- cells on pillars. A microscope coverslip holder and a stage-
top incubator (Tokai Hit, Japan) where the temperature was kept at 37°C and the CO2 
level at 5%, were used for the live imaging. Imaging of fixed samples was done after 
fixation with 4% paraformaldahyde. Cells were incubated for 8,5 hours after seeding 
them on micropillars before fixation.  
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2.3.2 Simulated ischemia, chemical stabilization of HIF-alpha and 
glucose deprivation 
 
Ischemia was simulated in the same way hypoxia was simulated. In addition, cells were 
deprived of the glucose. Because 40% of the CD31- cells died after one hour in ischemia 
[6], medium is exchanged by low glucose DMEM supplemented with 10% FBS, 25 
ug/ml penicillin and 25 ug/ml streptomycin, seven hours of incubation after seeding 
CD31- on pillars. Imaging of fixed samples was done after fixation with 4% 
paraformaldahyde. Cells were incubated for 8,5 hours after seeding them on micropillars 
and have been in ischemic condition for 1,5 hours before fixation. 
 
 
2.4 Immunostaining 
After fixation of the CD31- cells, the actin cytoskeleton was immunostained with Alexa 
532 labeled phalloidin (Signa-Aldrich) dissolved in PBS (1:500). Micropillar arrays with 
fixed cells were inverted onto a 100 uL droplet and incubated in dark for 1 hour. The cell 
nucleus was immunostained using a 300nM solution of 4',6-diamidino-2-phenylindole 
(DAPI, Sigma-Aldrich), diluted in PBS. Micropillar arrays with fixed cells were inverted 
onto a 100 uL droplet and incubated in dark for 5 minutes. After each immunostaining 
fixed cells were washed three times in PBS.  
 
 
2.5 Imaging 
Imaging was done on a home build confocal microscope. The body of the microscope is 
an Axiovert 200 (Zeiss). We used a spinning disk unit (CSU-X1, Yokogawa) to obtain 
the confocal image. The image is acquired on an emCCD camera (iXon 897, Andor). We 
used three different lasers with the wavelengths 405, 514 and 642 nm (CrystaLaser, 
Cobolt and SpectraPhysics, respectively). The basic set-up control and data acquisition 
was done with IQ-software (Andor) and the software for the autofocus and the automated 
XY positioning (Marzhauser XY-stage) is written in Labview, National Instruments [19]. 
 
 
2.6 Force analysis 
The forces exerted by the cell on the pillararrays were calculated by a homewritten 
program in Matlab (MatWorks). First of all, the program locates the exact pillar locations 
using a fit to the cross-correlation function between a perfect circle and the local 
fluorescence of the labeled fibronectin on one pillar [22]. The undeflected hexagonal grid 
was determined by comparing it with the exact pillar locations. The translation and the 
rotation of the undeflected hexagonal grid compared to the exact pillar locations is 
needed to overlay the two. Deflections of the exact pillar locations, referencing to the 
undeflected grid, were returned in a matfile. The program further maps the deflections to 
the original image, indicating the deflections with arrows. The bending stiffness of the 
pillars was taken into account. With finite element modeling (FEM) the bending 
stiffnessess of the micropillar arrays were determined [19]. Pillars on the arrays that we 
used in our experiments had characteristic bending stiffnesses of 𝑘𝑏𝑒𝑛𝑑 =191.1, 65.8, 
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41.2 and 16.2 nN/μm, respectively. These bending stiffnesses were calculated to 
correspond to a Young’s modulus in continuous substrates of approximately 11.6, 29.5,  
47.2 and 137 kPa respectively. The bending stiffness closely followed the predicted value 
obtained from the Euler-Bernoulli beam theory, see equation: 
 
𝐹 = 𝑘𝑏𝑒𝑛𝑑 𝛿 =
3𝜋
64
 𝐸 
𝑑4
ℎ3
 𝛿 
 
The force, F, has a linear relationship to the deflection, δ, and the bulk material, E. The 
force relates to the diameter of the pillar, d, to the forth power and the height of the pillar, 
h, to the third power.  
 
The analysis program calculated the forces with this relation. The deflected pillars, in the 
image were further selected manually. This has as a result that collapsed pillars are not 
taken into account for the force calculation, since they will give an error in the analysis.  
 
 
2.7 Cell spreading area analysis 
Cell spreading area measurement was done with Fiji [23]. Using a threshold intensity to 
get rid of background signal, the area of the fluorescently labeled actin cytoskeleton was 
selected. The analysis was done manually per image to obtain the area per single cell, 
since some cells were overlapping. The same was done for the area of the cell nucleus, 
making use of different fluorescence channels.  
 
 
2.8 Statistics 
Statistics were calculated in origin (originlab). For the force application, the mean force 
per pillar was calculated. The according errors were calculated using the standard error. 
The mean force application for each condition was shown in a column plot. 
 
For the area analysis, the areas of the cells and nuclei were first converted from the unit 
pixels to μm². Secondly the ratios between the nuclei areas and the cell spreading areas 
were calculated. These ratios were shown in a histogram for each condition. Then the 
mean was taken for the cell spreading areas. The error was calculated with the standard 
error. A column plot was used to show the mean cell spreading areas for each condition. 
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Results 
 
 
3.1 In vitro modelling of the hypoxic and ischemic 
conditions 
 
3.1.1 Determination of the DMOG concentration range 
In order to answer the question what the influence of hypoxia and ischemia is on the force 
application and the cell spreading area of pericytes, the nontoxic concentration of DMOG 
for CD31- cells was first determined. DMOG was used to simulate the hypoxic condition 
by inhibition of PHD. We looked at the viability of CD31- cells that were in 10 different 
concentrations DMOG for 48 hours. The concentrations DMOG that were used are 0, 
0.125, 0.25, 0.50, 1.0, 1.5, 2.0, 3.0, 4.0, 5.0 mM. We used a 24 well plate with each 
concentration in two wells. After seeding 20 000 CD31- cells of passage 8 in each well 
in normal culture medium, DMOG was added after 4 hours of incubation in this medium. 
The volume of DMOG that was necessary to get the above given concentrations was 
calculated with 𝑉1 = 𝑉2𝑀1/𝑀1, where V1 is the volume of the DMOG stock solution, V2 
is the volume of the medium to which DMOG was added, M1 is the 50mM stock 
concentration of DMOG and M2 is the concentration we wanted to obtain. After 48 hours, 
we checked the viability of cells with a 20X magnification microscope. 
 
We were unable to detect a clear transition in the viability of CD31- cells at a critical 
concentration. We found that for a concentration DMOG higher than 1.5 mM, cells 
looked round and we could classify them as dead cells. We looked at the viability of cells 
in 0.125, 0.5, 1.0 and 1.5 mM DMOG. Here CD31- cells had the same viability as in the 
control wells with no DMOG, but less cells were present when the concentration 
increased.  
 
Since our results showed no clear transition of viability of CD31- cells by a critical 
concentration DMOG between 0 and 1.5 mM, we consulted the literature. We found that 
for mesenchymal stemcells, which are alike with pericytes [24], a concentration above 1 
mM DMOG showed cytotoxicity [25]. Hence, we used this latter concentration in our 
further experiments with CD31- cells. 
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3.1.2 Chemical stabilization of hypoxia-inducible factor alpha (hypoxia)  
Live imaging 
CD31- cells were thawed and kept in culture in normal medium. Less than 24 hours after 
thawing, the medium was refreshed to remove the medium in which CD31- cells were 
frozen. After incubation overnight to let the cells recover 1mM DMOG was added. 
Incubation with DMOG was for 40 hours. Another petridish with CD31- cells was treated 
the same way without DMOG as a control. 
 
We prepared a 12-well plate with 2 micropillar arrays, each with a substrate elasticity of 
47.2 kPa. When cells were split to seed them on the micropillar arrays in the 12-well 
plate, we used all liquids containing 1.0 mM DMOG. The volume containing 20 000 
CD31- cells of passage 7 was added to the micropillar arrays. CD31- cells were left to 
attach to the fibronectin on the pillars for 4 hours. Imaging was done 4 hours and 8 hours 
after seeding, see figure 3.1 and 3.2. 
 
 
Figure 3.1: Live image of pericytes after 44 hours in 1mM DMOG (seeded on pillars with a 
substrate elasticity of 47.2 kPa after 40 hours in 1 mM DMOG). Imaged with a 100X objective. 
Grayscale: the brightfield, red: fluorescently labeled fibronectin. Left: The arrows indicate the 
forces that the pericyte exerts on the pillars. Right: The CD31- cell wrapped the fibronectin off 
the pillars.  
 
 
Figure 3.2: Live image of pericytes after 48 hours in 1mM DMOG (seeded on pillars with a 
substrate elasticity of 47.2 kPa after 40 hours in 1 mM DMOG). Imaged with a 100X objective. 
Grayscale: the brightfield, red: fluorescently labeled fibronectin. Left: The arrows indicate the 
forces that the pericyte applies to the pillars. Right: The CD31- cell wrapped the fibronectin off 
the pillars. 
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As can be seen in figure 3.1 and 3.2, fibronectin was wrapped off the pillars. This result 
could be because cells exert an unusual high force on the pillars which potentially 
allowed them to rip off fibronectin from the PDMS pillars. Secondary it could be a result 
of bad stamping due to ineffective UV-Ozone activation of PDMS. 
 
For the areas with remaining homogeneous stamping, we calculated the mean force per 
pillar, see figure 3.3. The mean force per pillar 4 hours after seeding cells on pillars, was 
5.0 ± 0.5 nN. 8 hours after seeding cells on pillars, the mean force per pillar was 18 ± 1 
nN.  
 
 
 
Figure 3.3: The mean forces that CD31- cells applied on micropillars with a substrate stiffness 
of 47.2 kPa after a total time in DMOG of 44 and 48 hours. The time after seeding CD31- on 
these pillars was 4 and 8 hours. 
 
 
Using different stock solutions of the fibronectin resulted in homogeneous stamping 
without empty areas. Excluding the empty areas of fibronectin as a result the high force 
of CD31- cells exert, bad stamping or bad unlabeled fibronectin, the following 
experiments were executed with imaging of fixed samples to avoid usage of the live-
measurement incubator. All conditions had an extra control pillar array to see for the 
micro printing of fibronectin.  
 
Imaging of fixed samples 
CD31- cells were thawed and kept in culture in normal medium. Less than 24 hours after 
thawing, the medium was refreshed. 1 mM DMOG was added and cells were incubated 
for 40 hours. As a control we had another petridish with CD31- cells that were treated 
the same, without DMOG.  
 
We prepared a 12-well plate with four micropillar arrays with a substrate elasticity of 
47.2 kPa. When cells were split to seed them on the micropillar arrays in the 12-well 
plate, we used all liquids containing 1.0 mM DMOG. The volume containing 20 000 
CD31- cells of passage 7 from the control petridish was added to the micropillar arrays, 
since the detachment of the cells in the hypoxia dish failed. 1.0 mM DMOG was added 
to two pillararrays for the hypoxic condition. We allowed the CD31- cells attach to the 
fibronectin on the pillars for 8,5 hours before fixing with 4% paraformaldahyde. After 
staining for the actin cytoskeleton and the cell nucleus, CD31- cells were imaged. In both  
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hypoxic and control condition, the fibronectin was pulled off. The control pillar arrays 
functionalized with fibronectin without cells seeded on top, had a stamping without 
empty areas. Having done the force analysis and the cell spreading analysis we found in 
hypoxia a mean force per pillar of 16.4 ± 0.2 nN and a mean cell spreading area of 8.9e2 
± 90 μm² and in normoxia a mean force of 23.3 ± 0.4 nN and a mean cell spreading area 
of 7.0e2 ± 70 μm², see figure 3.6. Also the ratio between the area of the nucleus and the 
cell was determined. This was done to see if there was a certain ratio showing dead and 
alive cells. A dead cell has larger ratio than a living cell, since it has a larger nucleus area 
compared to the area of the cell. 
 
 
   
Figure 3.4: Histogram of the ratios between the area of the nucleus and the cell in hypoxia (left) 
and normoxia (right). Also given are the mean ratio and the total number of counts. 
 
 
Figure 3.4 shows a histogram of the ratios between nucleus and cell area in hypoxia and 
normoxia. The mean ratio between the areas is in hypoxia 0.28 ± 0.02 and in the control 
0.31 ± 0.01.  
 
 
3.1.3 Combined chemical stabilization of HIF-alpha and glucose 
deprivation (ischemia) 
 
Imaging of fixed samples 
For the combined glucose deprivation and chemical stabilization of HIF-alpha to model 
ischemia, the same method was used as in the chemical stabilization of HIF-1alpha for 
the imaging of fixed samples. Another 20 000 cells were added on four additional 
micropillar arrays in the prepared 12-well plate, two meant for the ischemia and two 
meant for normoxia without glucose (starvation). Also here, 1 mM DMOG was added to 
the micropillar arrays meant for ischemia. After seven hours CD31- cells in normal 
conditions mainly attached. CD31- cells in hypoxia condition had a bigger surface area 
and appeared more elongated. At this point the normal medium was exchanged by low 
glucose medium for these four micropillar arrays with seeded CD31- cells. Cells were 
checked every 30 minutes for the viability. After 1,5 hours in ischemia, cells were fixed. 
Subsequally, cells were stained for the actin cytoskeleton and the cell nuclei and were 
imaged. In both ischemic and normal condition, the fibronectin was pulled off. The 
control pillar arrays functionalized with fibronectin without cells seeded on top, had 
stamping without empty areas. Besides, in ischemia many cells fell off the pillars when  
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inverting the micropillar array for imaging. Having done the force analysis and the cell 
spreading analysis we found in ischemia a mean force of 19.3 ±0.3 nN and a mean cel 
spreading area of 4.5e2 ± 40 μm² and in starvation a mean force of 18.6 ± 0.4 nN and a 
mean cell spreading area of 7.0e2 ± 80 μm², see figure 3.6. The ratio between the area of 
the nucleus and the cell was determined for the same reason previously explained. 
 
 
   
 
Figure 3.5: Histogram of the ratios between the area of the nucleus and the cell in ischemia (left) 
and starvation (right). Also given are the mean ratio and the total number of counts. 
 
 
Figure 3.5 shows a histogram of the ratios between nucleus and cell area in ischemic 
condition and starvation. The mean ratio between the areas is in ischemia 0.44 ± 0.02 and 
in starvation 0.42 ± 0.01.  
 
 
3.1.4 Statistics on the force application and the cell spreading area 
The mean force application and the mean cell spreading area in hypoxia, control, 
ischemia and starvation are shown in figure 3.6 for comparison. In hypoxic conditions 
CD31- cells have the lowest force application that had a value of 16.4 ± 0.2 nN. In normal 
conditions the force application is the highest: 23.3 ± 0.4 nN. In ischemic conditions and 
when cells were starved, cells have a force application of about the same value, 19.3 ± 
0.3 and 18.6 ± 0.4 nN.  
 
The cell spreading area in hypoxia had the highest value of 8.9e2 ± 90 μm². For the 
control condition this value was 7.0e2 ± 70 μm².  In ischemia the cell spreading area was 
by far the lowest, 4.5e2 ± 40 μm². Starving cells did not affect the cell spreading area, 
since cells had the same spreading area as in the control conditions. 
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Figure 3.6: Left: Mean force application per pillar of CD31- cells in hypoxia, control, ischemia 
and starvation. Right: Mean cell spreading area of CD31- cells in hypoxia, control, ischemia and 
starvation 
 
 
3.2 Effect of the substrate elasticity 
To see the effect of the micropillar elasticity we used a human fibroblast cell line, SV80. 
SV80 cells of passage 3 were seeded on functionalized micropillar arrays of 4 different 
effective stiffnesses, 11.6, 29.5, 47.2 and 137 kPa respectively. After four hours of 
incubation, SV80 cells were fixed with 4% paraformaldehyde and immunostained for the 
actin cytoskeleton. The mean force per pillar and the mean cell spreading area were 
calculated after imaging. The mean force per pillar and mean cell spreading area for each 
substrate stiffness is shown in figure 3.7. 
 
Figure 3.7 shows an increase in the mean force for increasing substrate elasticities. The 
mean force on a substrate with an elasticity of 137 kPa is slightly lower than the mean 
force on a substrate with elasticity of 47.2 kPa. However, this decrease is still in the 
region of both error bars. For the cell spreading area, we also found an increase for 
increasing substrate elasticities. The decrease in cell spreading area of cells on a substrate 
with an elasticity of 47.2 kPa might be an artifact.  
 
For CD31- cells was shown in a previous study (data unpublished) that the force 
application and cell spreading area had a different correlation with the substrate 
elasticities. For the force application the mean forces were between 15 and 40 nN. The 
force application was shown to be high on substrate that had an elasticity of 11.6 and 137 
kPa. And contrary to SV80 cells, CD31- cells had a low force application on substrates 
that had an elasticity of 29.5 and 47.2 kPa. The cell spreading areas of CD31- cells took 
values between 1000 and 3500 um². The mean areas were increasing for substrates with 
an elasticity of 11.6, 29.5 and 47.2 kPa respectively. On a substrate with an elasticity of 
137 kPa, cells had a very small mean cell spreading area. 
 
 
 
 
 
 
 24 
 
 
 
 
 
 
Figure 3.7: Left: The mean force application per pillar of SV80 cells on PDMS micropillar arrays 
with substrate elasticities of 11.6, 29.5, 47.2 and 137 kPa. Right: The mean cell spreading area 
of SV80 cells on micropillar arrays with substrate elasticities of 11.6, 29.5, 47.2 and 137 kPa. 
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Discussion 
 
 
 
4.1 Effect of hypoxia and ischemia on pericytes 
To come back to the first research question that was set, we showed that hypoxia and 
ischemia have an influence on the force application and the cell spreading area of 
pericytes. 
 
For the live imaging experiment in hypoxia, it was shown that the mean force per pillar 
applied by pericytes increased from 5.0 ± 0.5 nN to 18 ± 1.4 nN in four hours (figure 
3.3). This suggests that cells did not attach for long, four hours after they were seeded on 
pillars. After eight they attached further and applied a higher force. 
As for the imaging of fixed samples in hypoxia, the force was 16.4 ± 0.3 nN. Comparing 
the force exerted by cells in hypoxia in live imaging and imaging of fixed samples, the 
force application in imaging of fixed samples is slightly lower. Hayri Emrah Balcioglu 
showed that the cells applied a 20% lower force if they were imaged as fixed samples 
compared to if they were imaged live (data not shown). Taking into account this fact, the 
force exertion is consistent in both experiments. In the control condition, pericytes have 
a 23.3 ± 0.4 nN mean force application. This is the highest force application, comparing 
with other conditions. The same mean force per pillar was measured in previous 
experiments in normoxia (unpublished data). So, in hypoxia pericytes decrease their 
force application, which is in agreement with our hypothesis. The cell spreading area in 
hypoxia was 8.9e2 ± 90 μm², which is a larger area than in other conditions. The ratios 
between the areas of the nucleus and cell agree with this (figure 3.4 and 3.5). In hypoxia 
the mean ratio is 0.28 ± 0.01, which is the lowest ratio compared with other ratios. 
Assuming the nucleus to have the same area everywhere, pericytes have, thus, a bigger 
cell area in hypoxia.  
 
As described in Hall et al., 40% of the pericytes constrict and die in ischemic conditions 
after one hour [6]. We hypothesized that pericytes had a higher force application and a 
small cell spreading area. Our data, however, showed a decrease in force application 
compared with normal conditions, but an increase compared with hypoxic conditions. 
An explanation for this result is the way we simulated ischemia. Using DMOG to 
simulate oxygen deprivation might give a false effect on the ischemic condition. The 
increase of force exertion compared with hypoxia is in agreement with our hypothesis.  
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The small cell spreading area of cells in ischemia we retrieved in our results. We also 
saw the death of cells back in our results when imaging them. 
 
In starvation, pericytes have an equal spreading area as in the control condition. Thus, 
the glucose level has no influence on the cell spreading area. However, a lower force 
application was measured.  
 
As for our model, fibronectin was easily pulled off by pericytes. This was not due to the 
bad stamping since the functionalized control pillar arrays showed homogeneous 
stamping without empty areas. The areas with wrapped off fibronectin had as an effect 
that the mean cell spreading area was smaller. In our results we found a mean cell 
spreading area of 7.0e2 ± 70 μm² for the control condition. Comparing this with other 
experiments (data not shown), the cell spreading area was in the order of 3e3 μm². 
Another reason for fibronectin to be wrapped off easily could be the linkage between the 
PDMS micropillars and the fibronectin. When we changed the protocol from one hour to 
two hours of silanization, an excess of silane sank onto the silicon wafer. Besides silane 
is not bound to the surface of the silicon. Therefore silicon needs to have OH-groups, 
which could be obtained by placing the surface in a strongly oxidizing environment [26]. 
The excess of silane that is not bound to the surface of the wafer blends in the PDMS 
mixure before it is cured. It was indicated that silane-modified PDMS micropillars 
resulted in superhydro-oleophobicity by Pan et al. [27]. Since the relative hydrophobicity 
between the stamp and the micropillars is important for the fibronectin to be printed, it 
can influence the fibronectin adhesion in the end. 
 
 
4.2 Effect of the substrate elasticity on pericytes and 
fibroblasts 
 
For SV80, the substrate elasticity matters in the exerted cell force and the cell spreading 
area, as can be seen in figure 4.1. An increase in the mean force per pillar can be observed 
for increasing substrate stiffnesses. It takes for these cells less force to deform pillars with 
a low substrate stiffness. These results correspond to the model of fibroblasts adapting 
their internal stiffness to the substrate stiffness [28]. The cells elastic moduli are governed 
by cytoskeletal assembly and production of internal stresses and could therefore be 
compared to the cells force application. As for the cell spreading area, also an increase 
can be observed for increasing substrate stiffnesses, with the exception for 29.5 kPa.  
 
For pericytes, the correlation between the force application and the cell spreading area 
was shown to be different than for fibroblasts. Here, the force application is low on 
intermediate substrate stiffnesses. Contrary with a high force application on low and high 
stiffnesses. This could have to do with the different substrate elasticities of vessels in the 
vascular tree. Pericytes sense which vessel they are located on and adapt their force 
application and cell spreading area according to the stiffness of the vessel. 
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Conclusion 
 
 
 
 
The response from cells to the substrate stiffness was examined and it is shown in our 
results that when the substrate stiffness increases, also the force application and the cell 
spreading area of fibroblasts increased (figure 3.7). Therefore, the substrate elasticity can 
be sensed by cells. Also the environmental levels of glucose and the effect of oxygen 
were investigated for pericytes. Although in hypoxia cells relaxed and spreaded mostly, 
in ischemia they decreased in cell spreading area and died fasly. For the normoxic 
condition glucose had an impact on the force exertion, but not so much on the cell 
spreading area. Thus it can be concluded that the role of oxygen and of glucose is an 
important factor in cell survival, spreading and force exertion. The amount of fibronectin 
patches also has an effect on the cell spreading area of pericytes, as the cell spreading is 
higher in normal conditions without empty areas of fibronectin (unpublished data). 
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